What a 2025 study tells us about a receptor component involved in the brain’s response to hormonal changes.
An ordinary evening can feel very different during the symptomatic days of PMDD. Background noise becomes harder to tolerate, a question feels like another demand, and settling down after a stressful moment takes longer. The contrast with how you feel earlier in the month can be confusing, especially when the circumstances around you have barely changed.
Research into GABA-A receptors is helping scientists investigate the biology behind this sensitivity. A study published in July 2025 drew attention to a particular part of these receptors, called the delta subunit.
What the researchers found
The study involved 29 women with PMDD and 27 women without symptoms. In the PMDD group, researchers found a statistically significant decrease in expression of the gene that codes for the delta subunit, from the follicular phase before ovulation to the symptomatic luteal phase. The control group did not show this pattern.
Gene expression describes how actively a cell uses a gene’s instructions to produce a particular component. The finding points to a change in the regulation of delta production across the cycle. It does not establish how many functioning delta-containing receptors are present in the brain.
Why the delta subunit matters
GABA is a chemical messenger that helps reduce nerve cell excitability. It works through receptors, including GABA-A receptors, which receive its signal and influence how readily a nerve cell becomes active. This inhibitory signalling is an essential part of how the brain regulates its activity.
Each GABA-A receptor is assembled from five protein components called subunits. Their combination influences the receptor’s behaviour. Receptors containing the delta subunit are particularly sensitive to neuroactive steroids and contribute to a sustained form of inhibition known as tonic inhibition. You can think of this as a background brake that helps regulate how easily a nerve cell responds to stimulation.
To picture why this kind of regulation matters, imagine cooking dinner while music is playing and someone asks you a question. When you feel settled, you can answer and continue cooking. During a difficult phase of PMDD, the same situation can feel like too much at once. You might feel an urgent need for quiet or find yourself snapping before you have had time to think. This is an everyday illustration of changing sensitivity; linking that experience specifically to delta receptors remains a research question.
How hormonal changes enter the picture
After ovulation, progesterone rises. Some of it is converted into allopregnanolone, often shortened to ALLO, a neuroactive steroid that acts on GABA-A receptors. ALLO can strengthen the inhibitory effect of GABA, and its levels change across the menstrual cycle. This creates a changing chemical environment for the receptors.
Animal studies have shown that delta-containing receptors can adapt across the ovarian cycle. In a mouse study, increased expression of these receptors during a high-progesterone phase strengthened tonic inhibition and was accompanied by reduced anxiety-like behaviour. Preventing those receptor changes disrupted the usual reduction in nerve cell excitability.
This work helped establish receptor adaptation as a subject of interest in PMDD. If the system adjusts differently as neurosteroid levels change, the resulting effects on brain activity could also differ. The human findings give researchers a reason to investigate that possibility further.
A connection with emotional brain activity
The 2025 study also found that women with PMDD who had lower delta expression during the luteal phase showed greater activity in part of the right amygdala during an emotional task. The amygdala is involved in processing emotionally significant information. This association connects the expression finding with emotional brain activity, although it cannot show that one caused the other.
What this could mean for PMDD
The practical question is whether a better understanding of receptor adaptation can lead to more effective treatment. Further research needs to establish how delta regulation affects symptoms and whether targeting this process can relieve them.
For someone living with PMDD, an explanation for changing emotional sensitivity can help make an unsettling experience more understandable. There can be a painful gap between knowing how you would usually respond and finding yourself overwhelmed in the moment. Research into the biology of that gap deserves attention, alongside the everyday support needed to live with it.
Struggling with emotions or everyday demands during PMDD does not make you dramatic or weak. Research increasingly points to biological differences in how the brain responds to hormonal changes, helping explain why something that feels manageable one week can become overwhelming the next. Understanding this can help ease the self-blame that so often follows a difficult day.
References:
Stiernman L, Comasco E, Johansson M, Bixo M. (2025). Transcription of GABAA receptor subunits in circulating monocytes and association to emotional brain function in premenstrual dysphoric disorder. Translational Psychiatry, 15, 255.
Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors. Proceedings of the National Academy of Sciences, 100(24), 14439–14444.
Martinez PE et al. (2016). 5α-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology, 41(4), 1093–1102.
Maguire JL, Stell BM, Rafizadeh M, Mody I. (2005). Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nature Neuroscience, 8(6), 797–804.
